Information Provided By: 
Fly News Breaks for April 28, 2016
CNMD
Apr 28, 2016 | 08:05 EDT
Leerink analyst Richard Newitter raised his price target for CONMED to $53 from $47 after the company reported quarterly results, with revenue and EPS slightly above consensus. The analyst believes CONMED's Q1 was once again reflective of the company's "evolving turnaround," which he sees as moving in the right direction. Newitter adds that new product launches in Q2-Q4 will yield "more meaningful" top-line acceleration moving through the year. The analyst reiterates an Outperform rating on the shares.
News For CNMD From the Last 2 Days
There are no results for your query CNMD
